Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerBilling CodesEndocrine, Nutritional and Metabolic Diseases and DisordersDRG 615-adrenal-and-pituitary-procedures-without-cc-mcc
    Ask Trek AI about this page

    Adrenal and Pituitary Procedures without CC/MCC: Inpatient Reimbursement Overview

    DRG 615 encompasses inpatient admissions for adrenal and pituitary procedures performed without a Complication or Comorbidity or Major Complication or Comorbidity; it covers surgical treatments like adrenalectomy and transsphenoidal pituitary operations. Correct assignment matters for inpatient reimbursement because grouping into this Diagnosis-Related Group versus higher-severity groups affects Medicare payment rates tied to resource use.

    Customize your policy alerts

    Sign up for drg 615 policy alerts

    Get alerted when payer policies referencing 615 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 615 Overview

    DRG 615 covers inpatient admissions for adrenal and pituitary gland procedures without a Complication or Comorbidity or Major Complication or Comorbidity. This category includes surgical interventions such as adrenalectomy and transsphenoidal pituitary surgery when no additional coded CC or MCC is present. It matters for Medicare payment because the presence or absence of Complication or Comorbidity and Major Complication or Comorbidity affects relative payment weight and reimbursement classification. Accurate coding of procedures and comorbid conditions determines assignment to this Diagnosis-Related Group and thus influences Medicare inpatient payment.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative outcomes and surgical technique trials focusing on minimally invasive versus open approaches for adrenalectomies and transsphenoidal pituitary surgeries: these studies enroll patients scheduled for adrenal or pituitary procedures to compare intraoperative metrics (blood loss, operative time), complication rates, and short-term length of stay between approaches and technical variations. They address acute procedural care and are relevant to surgeons, hospital administrators, and payers because differences in complications and LOS directly affect inpatient resource utilization, cost, and DRG-related reimbursement.
    • Comparative effectiveness studies of perioperative endocrine management and complication prevention in patients with functional adrenal or pituitary tumors: these trials examine protocols for preoperative optimization (e.g., glucocorticoid or mineralocorticoid management, blood pressure control, and perioperative hormone replacement strategies) and evaluate rates of adrenal crisis, electrolyte disturbances, and readmissions. The patient population includes hormonally active tumor cases and medically complex patients; findings inform best practices that reduce perioperative morbidity and downstream costs important for clinicians and payers.
    • Post-discharge outcomes and quality-of-life cohort studies assessing long-term endocrine recovery, recurrent disease surveillance, and healthcare utilization after adrenal or pituitary surgery: these observational or registry-based studies follow patients after discharge to measure endocrine function restoration, need for lifelong hormone replacement, recurrence rates, outpatient visit frequency, and subsequent hospital readmissions. This stage-of-care research is relevant to providers and payers because it captures longer-term resource use and outcomes that influence total cost of care, readmission penalties, and decisions about follow-up intensity and care coordination.

    Related Codes

    614-ADRENAL-AND-PITUITARY-PROCEDURES-WITH-CC-MCC

    Adrenal and Pituitary Procedures with CC/MCC: Inpatient Reimbursement Overview

    616-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

    617-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-CC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

    618-AMPUTATION-OF-LOWER-LIMB-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITHOUT-CC-MCC

    Amputation of Lower Limb for Endocrine, Nutritional and Metabolic Disorders without CC/MCC: Inpatient Reimbursement Overview

    619-O-R-PROCEDURES-FOR-OBESITY-WITH-MCC

    O.R. Procedures for Obesity with MCC: Inpatient Reimbursement Overview

    620-O-R-PROCEDURES-FOR-OBESITY-WITH-CC

    O.R. Procedures for Obesity with CC: Inpatient Reimbursement Overview

    621-O-R-PROCEDURES-FOR-OBESITY-WITHOUT-CC-MCC

    O.R. Procedures for Obesity without CC/MCC: Inpatient Reimbursement Overview

    622-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-MCC

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with MCC: Inpatient Reimbursement Overview

    623-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITH-CC

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders with CC: Inpatient Reimbursement Overview

    624-SKIN-GRAFTS-AND-WOUND-DEBRIDEMENT-FOR-ENDOCRINE-NUTRITIONAL-AND-METABOLIC-DISORDERS-WITHOUT-CC-MCC

    Skin Grafts and Wound Debridement for Endocrine, Nutritional and Metabolic Disorders without CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 25

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.